期刊文献+

骨肉瘤组织中endocan、VEGF的表达及意义 被引量:2

Expression and significance of endocan and VEGF in osteosarcoma tissues
暂未订购
导出
摘要 目的探讨人骨肉瘤组织中endocan、血管内皮生长因子(VEGF)的表达状况及其与临床病理资料之间的相关性。方法应用SP法对34例经手术切除和病理证实的骨肉瘤组织中endocan、VEGF蛋白的表达进行检测。结果Endocan在骨瘤组织胞质中呈阳性表达,肿瘤周围的血管内皮细胞呈阳性表达。对照组表达无明显表达。分别记录各组的平均光密度(MOD),采用独立样本的t检验分析,两组之间差异有统计学意义。比较endocan、VEGF的MOD值,经Pearson相关统计分析,两组之间差异有统计学意义。En-docan、VEGF的MOD值与患者年龄及性别无相关性,与患者病程及肺转移有明显相关性;endocan、VEGF的MOD与肿瘤的类型有相关性。结论Endocan在骨肉瘤组织中有明显的表达,其表达与骨肉瘤的生长、转移有关,提示检测en-docan的表达对骨肉瘤的预后判断可能有一定的指导意义。 Objective To evaluate the expression of endocan and VEGF (vascular endothelial cell growth factor, VEGF) in osteosarcoma tissues and studied the clinicopathological characteristics and its clinical significance. Methods The expression of endoean and VEGF in 34 cases of oseosarcoma were examined with SP immunohisto- chemical technique. Results Endocan was high expressed in the cytoplasm of osteosareoma organization, and the vascular endothelial cells around the tumor were positived. There was no obvious in control group. Each of the mean value of optical density (MOD) was recorded. The differences between them were statistically significant after using independent sample t-test. The difference of endocan and VEGF's MOD was statistically significant after Pearson related statistical analysis. Through the analysis of its clinical data, we found: there were no statistical significance in age and sex; there had obvious difference in course and lung metastases, that was statistically significant; there had difference in types of tumors. Conclusion Endocan is expressed in osteosarcoma. There is correlation between the expression of endocan and the growth, transfer of oeteosarcoma.
出处 《安徽医科大学学报》 CAS 北大核心 2009年第6期695-698,共4页 Acta Universitatis Medicinalis Anhui
关键词 骨肉瘤 血管内皮生长因子 osteosarcoma vascular endothelial growth factors
  • 相关文献

参考文献12

  • 1Lassalle P, Molet S, Janin A, et al. ESM-I is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines[J]. Biol Chem,1996,271 (34) :20458 -64.
  • 2Aitkenhead M, Wang S J, Nakatsu M N, et al. Identification of endothelial cell genes expressed in an in vitro model of angiogenesis: induction of ESM-1, (beta) ig-h3, and NrCAM [J]. Microvasc Res,2002,63 (2) : 159 - 71.
  • 3Tsai J C, Zhang J, Minami T, et al. Cloning and characterization of the human lung endothelial-cell-specific molecule-1 promoter [J]. Vasc Res,2002,39(2) :148 -59.
  • 4熊江霞,张素梅,王雪,胡向阳,桂淑玉,周青,汪渊.抗人内皮细胞特异性分子-1单克隆抗体的研制和初步鉴定[J].现代免疫学,2004,24(3):217-220. 被引量:11
  • 5Ferrara N, Henzal W J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothlial cells [ J ]. Biochem Biophys Res Commun, 1989,161 ( 2 ) : 851 - 8.
  • 6Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing [J]. Biol Chem, 1991,266(18) :11947 -54.
  • 7Wei M H, Popescu N C, Lerman M I, et al. Localization of the human vascular endothelial growth factor gene, VEGF, at chromosome 6p12[J]. Hum Genet,1996,97(6) :794 -7.
  • 8Vincenti V, Cassano C, Rocchi M, et al. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3 [ J ]. Circulation, 1996, 93 ( 8 ) : 1493 - 5.
  • 9Duyndam M C, Hilhorst M C, Schluper H M, et al. Vascular endothelial growth factor-165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts[ J ]. Am J Pathol, 2002,160 ( 2 ) : 537 - 48.
  • 10Bechard D, Gentina T, Delehedde M, et al. Endocan is a novel chondroitin sulfate/dennatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity [ J ]. Biol Chem,2001,276(51) :48341 -9,.

二级参考文献15

  • 1汪渊,朱华庆,张素梅,王雪,伍权,储兵,陈厚早,卜丽佳,周青,桂淑玉.蛋白质印迹技术[J].安徽医科大学学报,2004,39(3):245-246. 被引量:4
  • 2Bechard D, Lassalle P, Molet S, et al. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines [ J ]. The Journal of Biological Chemistry, 1996,271(34) :20458 -64.
  • 3Bechard D, Meignin V, Scherpereel A, eta/. Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies [ J ]. J Vasc Res,2000,37 (5) :417 - 25.
  • 4Weilner M, Herse F,Janke J, et al. Endothelial cell specific molecule-1-A newly identified protein in adipocytes[J]. Horm Metab Res,2003,35(4) :217 -21.
  • 5Wang Y, Zhang J, Xian J Y, et al. Activation of ERK1/2 MAP kinase pathway induces tight junction disruption in human corneal epithelial cells[J]. Experimental Eye Research,2004,78( 1 ) :125-36.
  • 6Cai H,Jacobson K,Michael D, et al. MAP kinases and cell migration[J]. Journal of Cell Science,2004,117(20) :4619 -28.
  • 7Lassalla P, Molet S,Janin A, et al. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines[J]. J Biol Chem, 1996,271:20458.
  • 8Tsai JC, Zhang J, Voland C,et al. Cloning and characterization of the human lung endothelial-cell-specific molecule-1 promoter[J]. J Vasc Res, 2002,39:148.
  • 9Bechard D, Scherpereel A, Hammad H,et al. Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1[J]. J Immunol,2001,167:3099.
  • 10Nimmo GR,Lew AM,Stanley CM,et al.Influence of antibody on the performance of different antibodies assays[J]. J Immunol Methods.1984,72:117.

共引文献10

同被引文献27

  • 1董蕾,吴强,胡向阳,丁向东,汪渊,杨枫,左莉.涎腺腺样囊性癌组织中ESM-1 mRNA及其蛋白表达的关系[J].山东医药,2006,46(19):17-19. 被引量:2
  • 2Cadosch D, Toffoli AM, Gautschi OP, et al. Serum after traumatic brain injury increases proliferation and supports expression of osteoblast markers in muscle cells. J Bone Joint Surg Am, 2010, 92(3) :645-653.
  • 3Morley J, Marsh S, Drakoulakis E, et al. Does traumatic brain injury result in accderated fracture healing? Injury, 2005; 36(3):363-368.
  • 4Beamer B, Hettrich C, Lane J, et al. Vascular Endothelial Growth Factor: an essential component of angiogenesis and fracture healing. HSS J, 2010; 6(1 ):85- 94.
  • 5Weiss S, Zimmermann G, Pufe T, et al. The systemic angiogenic response during bone healing. Arch Or'chop Trauma Surg, 2009; 129(7):989-997.
  • 6Li R, Stewart DJ, von Schroeder HP, et al. Effect of cell-based VEGF gene therapy on healing of a segmental bone defect. J Orthop Res, 2009,27(1):8-14.
  • 7Toffoli AM, Gautschi OP, Frey SP, et al. From brain to bone: evidence for the release of osteogenic humoral factors after traumatic brain injury. Brain Inj, 2008; 22(7- 8):511 -518.
  • 8Gautschi OP, Cadosch D, Frey SP, et al. Serum-mediated osteogenie effect in traumatic brairvinjured patients. ANZ J Surg, 2009; 79(6) :449-455.
  • 9Reumann IVIK, Nair T, Strachna O, et al. Production of VEGF receptor 1 and 2 mRNA and protein during endochondral bone repair is differential and healing phase specific. J Appl Physiol, 2010; 109(6):1930-1938.
  • 10Boes M, Kain M, Kakar S, et al. Osteogenic effects of traumatic brain injury on experimental fracture-healing. J Bone Joint Surg Am, 2006; 88(4) :738-743.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部